Pregabalin-induced hyperprolactinemia in a patient with fibromyalgia: A case report.
North Clin Istanb
; 3(3): 233-236, 2016.
Article
em En
| MEDLINE
| ID: mdl-28275758
ABSTRACT
Several pharmacological and non-pharmacological modalities have been proposed for the treatment of fibromyalgia syndrome (FMS), a common rheumatic disease. Pregabalin is suggested as a first-step medication for FMS in the newest guidelines. Drowsiness, dizziness, and peripheral edema are well-known side effects of pregabalin; however, mastalgia is rarely seen. Presently described is a case of FMS in a patient who developed mastalgia and hyperprolactinemia (HPL) while taking pregabalin.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
Idioma:
En
Revista:
North Clin Istanb
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Turquia